Current stage-Stage 0 - Page 6 of 8 Posts on Medivizor
Navigation Menu

Current stage-Stage 0 Posts on Medivizor

Pathologic complete response to neoadjuvant therapy predicts prognosis in HER2-positive breast cancer

Pathologic complete response to neoadjuvant therapy predicts prognosis in HER2-positive breast cancer

Posted by on Aug 29, 2013 in Breast cancer | 0 comments

In a nutshell This study assessed the impact of pathologic complete response (pCR) to neoadjuvant chemotherapy and trastuzumab (herceptin) on survival of HER2-positive breast cancer patients. Some background Neoadjuvant therapy refers to treatments given before surgery in order to shrink the tumor and allow for complete surgical removal of the...

Read More

Tamoxifen reduces the risk of contralateral breast cancer in women with BRCA1 or BRCA2

Posted by on Aug 25, 2013 in Breast cancer | 0 comments

In a nutshell This study examined whether tamoxifen (nolvadex) can reduce the risk of contralateral breast cancer in women diagnosed with breast cancer and the BRCA1 or BRCA2 genetic mutation. Some background The BRCA1 and BRCA2 genetic mutations are associated with a high risk of developing breast cancer. While prophylactic mastectomies (a...

Read More

Does obesity influence how breast cancer patients will benefit from further hormonal therapy?

Does obesity influence how breast cancer patients will benefit from further hormonal therapy?

Posted by on Aug 20, 2013 in Breast cancer | 0 comments

In a nutshell This article investigated whether the body mass index or BMI (defined as weight divided by the square of height) can be used to determine how a patient with breast cancer treated with hormonal therapy may benefit from further treatment with a type of hormonal therapy called aromatase inhibitors. Some background Aromatase inhibitors...

Read More

Evaluating outcomes after a local recurrence following breast conserving surgery in young breast cancer patients

Evaluating outcomes after a local recurrence following breast conserving surgery in young breast cancer patients

Posted by on Aug 15, 2013 in Breast cancer | 0 comments

In a nutshell This study evaluated survival rates after a local recurrence (return of the cancer close to the place of the initial cancer) in young breast cancer patients treated with breast conserving surgery. Some background Young patients with early stage breast cancer are usually treated with breast conserving surgery or BCS (removal of the...

Read More

Comparing cosmetic outcomes for external versus intraoperative radiotherapy in breast cancer patients

Posted by on Aug 12, 2013 in Breast cancer | 0 comments

In a nutshell In this study, researchers examined two methods of delivering radiation therapy as a treatment for breast cancer. They compared the cosmetic outcomes of breasts treated with targeted intraoperative radiotherapy (TARGIT) or external beam radiotherapy (EBRT). Some background Medical and technological improvements have enhanced survival...

Read More

Evaluating complication rate for removal of one or both breasts in patients with breast cancer

Evaluating complication rate for removal of one or both breasts in patients with breast cancer

Posted by on Jul 30, 2013 in Breast cancer | 0 comments

In a nutshell In this study, researchers examined whether breast cancer patients who chose to have preventive removal of both breasts (bilateral mastectomy or BM) experience more post-surgery complications than patients who have removed only the cancer-affected breast (unilateral mastectomy or UM). Some background Most women with early breast...

Read More

Neoadjuvant chemotherapy does not reduce survival relative to surgery-first in breast cancer patients

Neoadjuvant chemotherapy does not reduce survival relative to surgery-first in breast cancer patients

Posted by on Jul 13, 2013 in Breast cancer | 0 comments

In a nutshell In this trial researchers examined whether the use of neoadjuvant chemotherapy (before surgery) influenced survival or recurrence rates in women undergoing breast conserving therapy for breast cancer. Some background Neoadjuvant chemotherapy (NCT) refers to chemotherapy treatments received prior to surgery. This approach is often...

Read More

Does high-fat dairy consumption influence survival or risk of recurrence in breast cancer patients?

Does high-fat dairy consumption influence survival or risk of recurrence in breast cancer patients?

Posted by on Jun 29, 2013 in Breast cancer | 0 comments

In a nutshell In this study, researchers investigated whether high-fat dairy products are linked to breast cancer recurrence (return of the cancer) in breast cancer patients. Some background High levels of estrogen (the main female sex hormone) represent one of the major causes of breast cancer. In Western cultures, most dairy cows have high...

Read More

Comparing survival after mastectomy and lumpectomy in patients with early-stage breast cancer

Posted by on Jun 28, 2013 in Breast cancer | 0 comments

In a nutshell The study compared survival rates in patients with early stage breast cancer treated with mastectomy versus lumpectomy plus radiation therapy. Some background Most breast cancers grow in response to female hormones (estrogen or progesterone), via their receptor (a protein found on the surface of the cancer cells). These cancers are...

Read More

Evaluating the effects of tamoxifen after surgery in women with ductal carcinoma in situ

Evaluating the effects of tamoxifen after surgery in women with ductal carcinoma in situ

Posted by on Jun 19, 2013 in Breast cancer | 0 comments

In a nutshell This review analyzed the effect of tamoxifen (Nolvadex) on survival and risk of recurrence (return of the cancer) in patients with ductal carcinoma in situ (DCIS).  Some background DCIS is a type of early-stage breast cancer. The cancer begins in the milk ducts of the breast breast and stays in its original place (in situ). This...

Read More

What are the risk factors for recurrence in patients with colorectal cancer?

What are the risk factors for recurrence in patients with colorectal cancer?

Posted by on Jun 15, 2013 in Colorectal cancer | 0 comments

In a nutshell This study aimed to identify risk factors for recurrence (return of the cancer) in patients with colorectal cancer following surgical removal.  Some background Colorectal cancer (CRC) is one of the most commonly diagnosed cancers. Treatment for CRC has generally involved surgery to remove the cancer along with the entire area...

Read More